Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ophiopogonis Radix fructan-selenium nanoparticles
- Development stage
- Preclinical
- Lead developer
- Boan Biotech
- Modality
- Nanoparticles → Drug Delivery Systems
- Administration
- Oral, Intravenous, Rectal
01
Overview
Ophiopogonis Radix fructan-selenium nanoparticles (ORP-SeNPs) are research-stage, polysaccharide-functionalized inorganic nanoparticles developed for the treatment of inflammatory bowel disease and colorectal cancer. The compound consists of elemental selenium nanoparticles stabilized and capped by fructan-type polysaccharides derived from the traditional Chinese medicinal herb *Ophiopogonis Radix*. Prepared via a redox reaction between sodium selenite and ascorbic acid, ORP-SeNPs function as a colon-targeted drug delivery system. Their therapeutic effects are mediated through the modulation of gut microbiota homeostasis, as well as intrinsic anti-inflammatory, antioxidant, and antitumor activities. The research was published in the International Journal of Biological Macromolecules in 2025 by a team of academic researchers.
- Other names
- Ophiopogonis Radix fructan-selenium nanoparticlesORP-SeNPsOphiopogonis Radix polysaccharide-selenium nanoparticles
Beyond the preview
Go deeper on Ophiopogonis Radix fructan-selenium nanoparticles.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ophiopogonis Radix fructan-selenium nanoparticles.